Healthcare Realty Trust's (HR) Buy Rating Reaffirmed at BTIG Research

Key Points

• Healthcare Realty Trust's stock received a "buy" rating from BTIG Research with a target price of $20.00, indicating a potential upside of 7.01% from its current price.
• The company reported earnings of $0.41 per share for the last quarter, slightly exceeding analyst expectations of $0.40.
• Various analysts have differing ratings on the stock, with a consensus of a "Hold" and an average price target of $17.67.

BTIG Research reiterated their buy rating on shares of Healthcare Realty Trust (NYSE:HR - Free Report) in a research report sent to investors on Wednesday,Benzinga reports. The firm currently has a $20.00 price target on the real estate investment trust's stock.

Other research analysts have also issued reports about the stock. Wells Fargo & Company increased their price objective on shares of Healthcare Realty Trust from $15.00 to $16.00 and gave the stock an "underweight" rating in a report on Wednesday, August 27th. Wall Street Zen cut shares of Healthcare Realty Trust from a "hold" rating to a "sell" rating in a research report on Saturday, May 31st. Scotiabank upgraded shares of Healthcare Realty Trust from a "sector perform" rating to a "sector outperform" rating and boosted their price objective for the stock from $18.00 to $20.00 in a research note on Friday, September 5th. Finally, JPMorgan Chase & Co. decreased their price objective on shares of Healthcare Realty Trust from $18.00 to $17.00 and set a "neutral" rating for the company in a research note on Thursday, June 26th. Two analysts have rated the stock with a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $17.67.

Healthcare Realty Trust Price Performance

NYSE:HR traded down $0.24 on Wednesday, reaching $18.11. The stock had a trading volume of 2,031,769 shares, compared to its average volume of 3,219,255. The company has a market cap of $6.37 billion, a price-to-earnings ratio of -15.74 and a beta of 0.94. The firm's fifty day moving average is $16.74 and its two-hundred day moving average is $15.99. Healthcare Realty Trust has a 12-month low of $14.09 and a 12-month high of $18.90.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last released its earnings results on Thursday, July 31st. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The company had revenue of $287.07 million for the quarter, compared to analyst estimates of $290.83 million. Healthcare Realty Trust had a negative net margin of 32.95% and a negative return on equity of 7.70%. During the same period in the prior year, the firm earned $0.38 EPS. Healthcare Realty Trust has set its FY 2025 guidance at 1.570-1.610 EPS. As a group, research analysts forecast that Healthcare Realty Trust will post 1.59 earnings per share for the current fiscal year.

Healthcare Realty Trust Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, August 28th. Investors of record on Thursday, August 14th were paid a dividend of $0.24 per share. This represents a $0.96 dividend on an annualized basis and a dividend yield of 5.3%. The ex-dividend date was Thursday, August 14th. Healthcare Realty Trust's payout ratio is currently -83.48%.

Insider Transactions at Healthcare Realty Trust

In related news, EVP Julie F. Wilson sold 15,000 shares of Healthcare Realty Trust stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $18.00, for a total transaction of $270,000.00. Following the sale, the executive vice president directly owned 113,419 shares in the company, valued at $2,041,542. The trade was a 11.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Thomas N. Bohjalian acquired 10,000 shares of the business's stock in a transaction that occurred on Wednesday, August 13th. The shares were bought at an average price of $16.46 per share, for a total transaction of $164,600.00. Following the completion of the purchase, the director owned 75,520 shares of the company's stock, valued at approximately $1,243,059.20. This represents a 15.26% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.37% of the stock is owned by insiders.

Institutional Investors Weigh In On Healthcare Realty Trust

A number of hedge funds and other institutional investors have recently modified their holdings of HR. Golden State Wealth Management LLC bought a new stake in shares of Healthcare Realty Trust during the first quarter valued at about $26,000. SVB Wealth LLC bought a new stake in shares of Healthcare Realty Trust during the first quarter valued at about $35,000. Anchor Investment Management LLC bought a new stake in shares of Healthcare Realty Trust during the first quarter valued at about $38,000. Lazard Asset Management LLC acquired a new position in Healthcare Realty Trust during the fourth quarter worth about $45,000. Finally, Financial Gravity Companies Inc. acquired a new position in Healthcare Realty Trust during the second quarter worth about $45,000.

About Healthcare Realty Trust

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.